Last reviewed · How we verify

NCT03640975: CLOE

Innate Immunity in Eosinophilic Esophagitis

Completed Last updated 5 March 2026
What this trial tests

trial testing Endoscopy in Eosinophilic Esophagitis in 35 participants. Completed in 28 October 2019.

Timeline
11 July 2018
Primary endpoint
28 October 2019
28 October 2019

Quick facts

Lead sponsorAssistance Publique - Hôpitaux de Paris
StatusCompleted
Study typeOBSERVATIONAL
Enrollment35
Start date11 July 2018
Primary completion28 October 2019
Estimated completion28 October 2019
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Assistance Publique - Hôpitaux de Paris — full company profile →

Who can join

Adults 1 to 18, any sex, with Eosinophilic Esophagitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main aim of this study is to assess the expression of innate lymphoid cells in the esophageal mucosa of children with eosinophilic esophagitis (EoE) and in control subjects

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Endoscopy

Trials testing the same drug.

Other recruiting trials for Eosinophilic Esophagitis

Currently open trials in the same condition.

Other Assistance Publique - Hôpitaux de Paris trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03640975.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing